KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Assets (2016 - 2025)

Sarepta Therapeutics (SRPT) has 15 years of Return on Assets data on record, last reported at 0.06% in Q3 2025.

  • For Q3 2025, Return on Assets fell 4.0% year-over-year to 0.06%; the TTM value through Sep 2025 reached 0.06%, down 4.0%, while the annual FY2024 figure was 0.04%, 13.0% up from the prior year.
  • Return on Assets reached 0.06% in Q3 2025 per SRPT's latest filing, down from 0.07% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.1% in Q3 2024 and bottomed at 0.24% in Q1 2021.
  • Average Return on Assets over 5 years is 0.08%, with a median of 0.09% recorded in 2023.
  • Peak YoY movement for Return on Assets: decreased -10bps in 2023, then increased 30bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.14% in 2021, then skyrocketed by 42bps to 0.08% in 2022, then decreased by -11bps to 0.09% in 2023, then soared by 141bps to 0.04% in 2024, then soared by 63bps to 0.06% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.06% in Q3 2025, 0.07% in Q2 2025, and 0.03% in Q1 2025.